{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:47:57Z","timestamp":1783226877179,"version":"3.54.6"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1097\/mnm.0b013e32833845b7","type":"journal-article","created":{"date-parts":[[2010,3,18]],"date-time":"2010-03-18T09:36:17Z","timestamp":1268904977000},"page":"576-582","source":"Crossref","is-referenced-by-count":21,"title":["Performance of FDG PET\/CT in postoperative colorectal cancer patients with a suspected recurrence and a normal CEA level"],"prefix":"10.1097","volume":"31","author":[{"given":"Jai Hyuen","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Gun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keum Nahn","family":"Jee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Guk","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwan","family":"Namgung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Il Han","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-16-20210212","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1200\/JCO.1999.17.3.894","article-title":"Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glucose in recurrent colorectal cancer","volume":"17","author":"Flamen","year":"1999","journal-title":"J Clin Oncol"},{"key":"R3-16-20210212","first-page":"492","article-title":"The clinical impact of (18)F-FDG PET in patients with suspected or confirmed recurrence of colorectal cancer: a prospective study","volume":"43","author":"Kalff","year":"2002","journal-title":"J Nucl Med"},{"key":"R4-16-20210212","first-page":"5195","article-title":"Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer","volume":"20","author":"Reiter","year":"2000","journal-title":"Anticancer Res"},{"key":"R5-16-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.suronc.2006.06.001","article-title":"Colorectal cancer follow-up: useful or useless?","volume":"15","author":"Li Destri","year":"2006","journal-title":"Surg Oncol"},{"key":"R6-16-20210212","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/1097-0142(19850315)55:6<1284::AID-CNCR2820550622>3.0.CO;2-B","article-title":"Results of a 400-patient carcinoembryonic antigen second-look colorectal cancer study","volume":"55","author":"Minton","year":"1985","journal-title":"Cancer"},{"key":"R7-16-20210212","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.1993.03510080047030","article-title":"An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer","volume":"270","author":"Moertel","year":"1993","journal-title":"JAMA"},{"key":"R8-16-20210212","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/BF02605759","article-title":"A retrospective study of serial CEA determinations in the early detection of recurrent colorectal cancer","volume":"24","author":"Wedell","year":"1981","journal-title":"Dis Colon Rectum"},{"key":"R9-16-20210212","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000140690","article-title":"Pre-operative staging with positron emission tomography in patients with pelvic recurrence of rectal cancer","volume":"25","author":"Faneyte","year":"2008","journal-title":"Dig Surg"},{"key":"R10-16-20210212","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1007\/s00259-009-1081-5","article-title":"Performance of integrated FDG PET\/contrast-enhanced CT in the diagnosis of recurrent colorectal cancer: comparison with integrated FDG PET\/non-contrast-enhanced CT and enhanced CT","volume":"36","author":"Kitajima","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R11-16-20210212","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0748-7983(95)97046-0","article-title":"Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging","volume":"21","author":"Schiepers","year":"1995","journal-title":"Eur J Surg Oncol"},{"key":"R12-16-20210212","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1477-7819-5-64","article-title":"FDG PET scan in patients with clinically and\/or radiologically suspicious colorectal cancer recurrence but normal CEA","volume":"5","author":"Sarikaya","year":"2007","journal-title":"World J Surg Oncol"},{"key":"R13-16-20210212","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s00259-006-0072-z","article-title":"The role of FDG PET\/CT in the detection of recurrent colorectal cancer","volume":"33","author":"Votrubova","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R14-16-20210212","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1046\/j.1365-2168.1999.01178.x","article-title":"Clinical assessment of positron emission tomography for the diagnosis of local recurrence in colorectal cancer","volume":"86","author":"Takeuchi","year":"1999","journal-title":"Br J Surg"},{"key":"R15-16-20210212","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1148\/radiol.2323031065","article-title":"Detection of recurrence in patients with rectal cancer: PET\/CT after abdominoperineal or anterior resection","volume":"232","author":"Even-Sapir","year":"2004","journal-title":"Radiology"},{"key":"R16-16-20210212","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.3748\/wjg.v13.i37.5025","article-title":"(18)F-DG PET\/CT in detection of recurrence and metastasis of colorectal cancer","volume":"13","author":"Chen","year":"2007","journal-title":"World J Gastroenterol"},{"key":"R17-16-20210212","first-page":"1797","article-title":"Direct comparison of (18)F-FDG PET and PET\/CT in patients with colorectal carcinoma","volume":"44","author":"Cohade","year":"2003","journal-title":"J Nucl Med"},{"key":"R18-16-20210212","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0959-8049(01)00049-1","article-title":"Unexplained rising carcinoembryonic antigen (CEA) in the postoperative surveillance of colorectal cancer: the utility of positron emission tomography (PET)","volume":"37","author":"Flamen","year":"2001","journal-title":"Eur J Cancer"},{"key":"R19-16-20210212","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00000658-199803000-00001","article-title":"Utility of FDG PET for investigating unexplained plasma CEA elevation in patients with colorectal cancer","volume":"227","author":"Flanagan","year":"1998","journal-title":"Ann Surg"},{"key":"R20-16-20210212","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1095-0397(00)00082-0","article-title":"16. FDG PET in the detection of recurrence in colorectal cancer based on rising CEA level. Experience in 72 patients","volume":"3","author":"Maldonado","year":"2000","journal-title":"Clin Positron Imaging"},{"key":"R21-16-20210212","first-page":"348","article-title":"Clinical impact of 18F-FDG PET in the suspicion of recurrent colorectal cancer based on asymptomatically elevated serum level of carcinoembryonic antigen (CEA) in Taiwan","volume":"53","author":"Shen","year":"2006","journal-title":"Hepatogastroenterology"},{"key":"R22-16-20210212","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s10350-008-9406-1","article-title":"Negative serum carcinoembryonic antigen has insufficient accuracy for excluding recurrence from patients with Dukes C colorectal cancer: analysis with likelihood ratio and posttest probability in a follow-up study","volume":"51","author":"Hara","year":"2008","journal-title":"Dis Colon Rectum"},{"key":"R23-16-20210212","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.suronc.2008.05.008","article-title":"Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer","volume":"18","author":"Tan","year":"2009","journal-title":"Surg Oncol"},{"key":"R24-16-20210212","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10350-003-0041-6","article-title":"Does serum CA19-9 play a practical role in the management of patients with colorectal cancer?","volume":"47","author":"Morita","year":"2004","journal-title":"Dis Colon Rectum"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0b013e32833845b7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:41:39Z","timestamp":1620963699000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-201006000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e32833845b7","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}